To further investigate the c-Myc/Prox1 interaction, we assessed whether c-Myc over-expression from an artificial promoter, lacking the Prox1 binding sites of the endogenous c-Myc gene, could rescue the anti-proliferative effect of Prox1 on breast cancer cells. The gene discussed is MYC; the disease is breast carcinoma.